ICFTD 2018

11th International Conference on Frontotemporal Dementia to be held Sydney Australia from 11-14 November 2018

[ICFTD 2018 @Icftd2018]

https://t.co/2o5URqNKqw

[Thomas Cope @tccambs]

Really delighted to have my work recognised by @Icftd2018, and also delighted for the notorious RBJ.

[Bluefield Project @BluefieldProj]

Cheers to @Icftd2018 organizers for a tremendous meeting and for creating an extraordinary home away from home in Sydney these last 3 days. And thanks to all participants for your continued commitment to #endFTD. See you in Minneapolis October 7-10, 2020 for #icftd2020!

[FTDtalk @FTDtalk]

What a fantastic meeting! Team @ftdtalk have learned a huge amount, made lots of new collaborations and can’t wait to see where the FTD field has got to by Minneapolis in 2020! #icftd2018

[FTDtalk @FTDtalk]

Congratulations to both @DrIoneW and Martina Bocchetta from team @FTDtalk who won the runners up prize in the PhD and postdoctoral categories. #icftd2018

[The AFTD @AFTDHope]

Bruce Miller @UCSF: “I’m an optimist. In the next 2 years, I hope and believe that we will have effective disease-modifying therapies for the genetic forms of FTD.” #icftd2018 #hopefor2020 #endFTD

[ICFTD 2018 @Icftd2018]

A fantastic end to #icftd2018! Thank you to all the speakers, delegates, organisers and of course the patients and their families without whom this important research wouldn’t be possible. #endFTD @Olivier_Piguet

[ICFTD 2018 @Icftd2018]

Congratulations to Dr Michael Ward for winning best #ECR abstract

[ICFTD 2018 @Icftd2018]

Congratulations to @SidRamanan for winning the best student abstract!

[ICFTD 2018 @Icftd2018]

Dr Marsel Mesulam, our final speaker for #icftd2018, provides a justification for multicentre trials of cholinesterase inhibitors for #PPA patients that have AD biomarkers, based on evidenced cholinergic denervation in areas that match the clinical profile of #PPA. #endftd

[The AFTD @AFTDHope]

Jary Larsen, FTD Disorders Registry: My hope for the next 2 years is that we'll have treatment interventions in the pipeline, especially for the genetic forms of FTD” #icftd2018 #hopefor2020

[ICFTD 2018 @Icftd2018]

Dr Zac Chatterton discusses early proof of concept evidence supporting development of liquid biopsies for detection of neurodegeration. @BrainMind_Usyd @Frontier_Usyd #icftd2018 #endftd

[The AFTD @AFTDHope]

Chiadi Onyike @JohnsHopkins: “My hopes: that we can develop biomarkers that will allow us to make an affirmative diagnosis, & for refinements in clinical measurements, esp. for the transition from asymptomatic to symptomatic in mutation carriers… #icftd2018 #hopefor2020

[Dr Anna Volkmer @volkmer_anna]

Smoothly does it, the brilliant @cjdhardy chairing this afternoons session @Icftd2018 introducing the great @charl_marshall #icftd2018 #dreamteam #PPA @RareDementia @PPAsupport_UK @ucl

[Dr Anna Volkmer @volkmer_anna]

The third day of @Icftd2018 #icftd2018 - (nearly) last but certainly not least the great @charl_marshall highlighting the impaired emotional processing in FTD

[ICFTD 2018 @Icftd2018]

Dr Dennis Dickson presents clinicopathological comparisons of GRN/C9orf72 - suggests greater microglial dysfunction in FTD-GRN. Also, FTD-GRN typically presented with asymmetric clinical features and atrophy while C9 often had symmetry in clinical features and atrophy #icftd2018

[Sherry Chen @Sherry_YuChen]

Please also come to my poster today at number 36 and 37 for more interesting findings about the role of cerebellum in frontotemporal dementia #Icftd2018

[Fiona Bright @DrFionaBright]

Amazing conference dinner at Luna park Sydney! @Icftd2018

[MLSE @MLSE_Study]

Our Research Fellow @Nikil__Patel will be presenting language impairments in PSP and CBS compared to PNFA on behalf of @kapeterson14. Please come along to poster W98 today to see our latest results. @Icftd2018 @CambridgeFTD #endFTD #ppa @pg220